IDH1 and glioblastoma: In patients in the FAS solely with IDH1-WT GBM (n = 85), the mOS was 24.8 months (95% CI: 19.7–26.3) and the mPFS was 14.8 months (95% CI: 11.7–17.2) (Figure S3).